These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15893118)

  • 41. Amygdala volume and verbal memory performance in schizophrenia and bipolar disorder.
    Killgore WD; Rosso IM; Gruber SA; Yurgelun-Todd DA
    Cogn Behav Neurol; 2009 Mar; 22(1):28-37. PubMed ID: 19372768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between absence of the adhesio interthalamica and amygdala volume in schizophrenia.
    Takahashi T; Suzuki M; Nakamura K; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
    Psychiatry Res; 2008 Feb; 162(2):101-11. PubMed ID: 18226506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Functional imaging of emotions and emotional dysfunctions in schizophrenia patients].
    Schneider F; Reske M; Backes V; Habel U
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S8-15. PubMed ID: 18461549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent.
    Silver H; Bilker W; Goodman C
    Psychiatry Res; 2009 Sep; 169(2):101-6. PubMed ID: 19692127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural pathology underlying neuroendocrine dysfunction in schizophrenia.
    Goldman MB; Wang L; Wachi C; Daudi S; Csernansky J; Marlow-O'Connor M; Keedy S; Torres I
    Behav Brain Res; 2011 Mar; 218(1):106-13. PubMed ID: 21093493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia.
    Gothelf D; Soreni N; Nachman RP; Tyano S; Hiss Y; Reiner O; Weizman A
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):389-95. PubMed ID: 10974611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A possible role of hippocampal dysfunction in schizophrenic symptomatology.
    Luchins DJ
    Biol Psychiatry; 1990 Jul; 28(2):87-91. PubMed ID: 2378923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hippocampal injury and chronic schizophrenia.
    Weinberger DR
    Biol Psychiatry; 1991 Mar; 29(5):509-11. PubMed ID: 2018826
    [No Abstract]   [Full Text] [Related]  

  • 50. Pathology, phenomenology and the dopamine hypothesis of schizophrenia.
    McKenna PJ
    Br J Psychiatry; 1987 Sep; 151():288-301. PubMed ID: 3322465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emotional and other effects of hypothalamic stimulation oppositely modified by dorsal and ventral hippocampus lesions.
    Psatta DM
    Neurol Psychiatr (Bucur); 1979; 17(2):121-31. PubMed ID: 573495
    [No Abstract]   [Full Text] [Related]  

  • 52. [The influence of limbic dysfunctions on the aetiology of childhood psychoses (author's transl)].
    Eggers C
    Fortschr Neurol Psychiatr; 1981 Mar; 49(3):101-8. PubMed ID: 7227960
    [No Abstract]   [Full Text] [Related]  

  • 53. Correlations between abnormal hippocampal morphology and prefrontal physiology in schizophrenia.
    Weinberger DR; Berman KF; Torrey EF
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():393A-394A. PubMed ID: 1498889
    [No Abstract]   [Full Text] [Related]  

  • 54. Cognitive dysfunction resulting from hippocampal hyperactivity--a possible cause of anxiety disorder?
    McNaughton N
    Pharmacol Biochem Behav; 1997 Apr; 56(4):603-11. PubMed ID: 9130284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resilience and Vulnerability to Pain and Inflammation in the Hippocampus.
    Vasic V; Schmidt MHH
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advancing a neurodevelopmental origin for schizophrenia.
    Bloom FE
    Arch Gen Psychiatry; 1993 Mar; 50(3):224-7. PubMed ID: 8439244
    [No Abstract]   [Full Text] [Related]  

  • 57. The hippocampus and cognitive impairments.
    Arushanyan EB; Beier EV
    Neurosci Behav Physiol; 2008 Oct; 38(8):751-8. PubMed ID: 18802776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hippocampal damage and schizophrenia: a critique of Mednick's theory.
    Kessler P; Neale JM
    J Abnorm Psychol; 1974 Apr; 83(2):91-6. PubMed ID: 4207616
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pathology of the anterior part of the hypothalamus].
    RABL R
    J Hirnforsch; 1957; 3(1):1-23. PubMed ID: 13449316
    [No Abstract]   [Full Text] [Related]  

  • 60. Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia.
    Prestia A; Cavedo E; Boccardi M; Muscio C; Adorni A; Geroldi C; Bonetti M; Thompson PM; Frisoni GB
    Am J Geriatr Psychiatry; 2015 Jan; 23(1):47-58. PubMed ID: 24534522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.